SEC Form 4 · accession 0001127602-18-022788

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Jul 2, 2018

Accepted (ET)

Jul 5, 2018 · 11:29 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 2, 2018	S	6	$111.445	D	274,445	D
Common Stock	Jul 2, 2018	S	200	$111.46	D	274,245	D
Common Stock	Jul 2, 2018	S	129	$111.47	D	274,116	D
Common Stock	Jul 2, 2018	S	355	$111.48	D	273,761	D
Common Stock	Jul 2, 2018	S	205	$111.49	D	273,556	D
Common Stock	Jul 2, 2018	S	293	$111.50	D	273,263	D
Common Stock	Jul 2, 2018	S	200	$111.53	D	273,063	D
Common Stock	Jul 2, 2018	S	200	$111.54	D	272,863	D
Common Stock	Jul 2, 2018	S	200	$111.57	D	272,663	D
Common Stock	Jul 2, 2018	S	200	$111.58	D	272,463	D
Common Stock	Jul 2, 2018	S	275	$111.59	D	272,188	D
Common Stock	Jul 2, 2018	S	100	$111.61	D	272,088	D
Common Stock	Jul 2, 2018	S	112	$111.625	D	271,976	D
Common Stock	Jul 2, 2018	S	200	$111.68	D	271,776	D
Common Stock	Jul 2, 2018	S	100	$111.69	D	271,676	D
Common Stock	holding	—	—		—	10,208	I	2016 GRAT
Common Stock	holding	—	—		—	29,954	I	2017 GRAT
Common Stock	holding	—	—		—	340	I	By Trust
Common Stock	holding	—	—		—	10,000	I	Held By Spouse

No Table II lines on this filing.